Correlation Between Qualigen Therapeutics and Neffs Bancorp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Neffs Bancorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Neffs Bancorp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Neffs Bancorp, you can compare the effects of market volatilities on Qualigen Therapeutics and Neffs Bancorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Neffs Bancorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Neffs Bancorp.

Diversification Opportunities for Qualigen Therapeutics and Neffs Bancorp

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Qualigen and Neffs is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Neffs Bancorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neffs Bancorp and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Neffs Bancorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neffs Bancorp has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Neffs Bancorp go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Neffs Bancorp

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Neffs Bancorp. But the stock apears to be less risky and, when comparing its historical volatility, Qualigen Therapeutics is 1.42 times less risky than Neffs Bancorp. The stock trades about -0.13 of its potential returns per unit of risk. The Neffs Bancorp is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  18,235  in Neffs Bancorp on August 29, 2024 and sell it today you would earn a total of  9,765  from holding Neffs Bancorp or generate 53.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Qualigen Therapeutics  vs.  Neffs Bancorp

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Neffs Bancorp 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neffs Bancorp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Neffs Bancorp sustained solid returns over the last few months and may actually be approaching a breakup point.

Qualigen Therapeutics and Neffs Bancorp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and Neffs Bancorp

The main advantage of trading using opposite Qualigen Therapeutics and Neffs Bancorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Neffs Bancorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neffs Bancorp will offset losses from the drop in Neffs Bancorp's long position.
The idea behind Qualigen Therapeutics and Neffs Bancorp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios